Cytokinetics, Incorporated (CYTK) vs Praxis Precision Medicines, Inc. (PRAX)
- Cytokinetics, Incorporated CYTK 54.64 −1.64%
- Praxis Precision Medicines, Inc. PRAX 275.38 +4.87%
Cytokinetics, Incorporated and Praxis Precision Medicines, Inc. are both Biotechnology companies. Cytokinetics, Incorporated and Praxis Precision Medicines, Inc. are of similar size ($7.7B and $7.3B). Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 29.9%. Praxis Precision Medicines, Inc. has the higher net margin (0.00% vs −686.6%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 16 metrics below, Praxis Precision Medicines, Inc. leads on 9 and Cytokinetics, Incorporated on 7.
Valuation
Profitability
| Metric | CYTK | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | (625.15%) | 0.00% | 0.00% |
| Net margin | (686.63%) | 0.00% | 0.00% |
| Free cash flow margin | (519.53%) | 0.00% | 0.00% |
| Return on equity | 184.71% | (38.86%) | (50.12%) |
| Return on assets | (47.70%) | (36.80%) | (45.60%) |
| Return on invested capital | 0.00% | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack